Clinical Trials Browser

Pancreatic Cancer Non-resectable × Gastrointestinal × 90 days × Clear all

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Phase 2 Enrolling by invitation

Gastrointestinal

Pancreatic Cancer Non-resectable

NCT07302841 2025-12-24

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Phase 4 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Non-resectable